BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

422 related articles for article (PubMed ID: 19817810)

  • 1. The teratogenic risk of antiepileptic drug polytherapy.
    Vajda FJ; Hitchcock AA; Graham J; O'Brien TJ; Lander CM; Eadie MJ
    Epilepsia; 2010 May; 51(5):805-10. PubMed ID: 19817810
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antiepileptic drug combinations not involving valproate and the risk of fetal malformations.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Eadie MJ
    Epilepsia; 2016 Jul; 57(7):1048-52. PubMed ID: 27265509
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The prescribing of antiepileptic drugs for pregnant Australian women.
    Vajda FJ; Horgan D; Hollingworth S; Graham J; Hitchcock AA; Roten A; O'Brien TJ; Lander CM; Eadie MJ
    Aust N Z J Obstet Gynaecol; 2012 Feb; 52(1):49-53. PubMed ID: 21910695
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fetal effects of anticonvulsant polytherapies: different risks from different drug combinations.
    Holmes LB; Mittendorf R; Shen A; Smith CR; Hernandez-Diaz S
    Arch Neurol; 2011 Oct; 68(10):1275-81. PubMed ID: 21670385
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Teratogenesis in repeated pregnancies in antiepileptic drug-treated women.
    Vajda FJ; O'Brien TJ; Lander CM; Graham J; Roten A; Eadie MJ
    Epilepsia; 2013 Jan; 54(1):181-6. PubMed ID: 22882134
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Final results from 18 years of the International Lamotrigine Pregnancy Registry.
    Cunnington MC; Weil JG; Messenheimer JA; Ferber S; Yerby M; Tennis P
    Neurology; 2011 May; 76(21):1817-23. PubMed ID: 21606453
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Navigating toward fetal and maternal health: the challenge of treating epilepsy in pregnancy.
    Tomson T; Perucca E; Battino D
    Epilepsia; 2004 Oct; 45(10):1171-5. PubMed ID: 15461670
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Comparing the General Practice Research Database and the UK Epilepsy and Pregnancy Register as tools for postmarketing teratogen surveillance: anticonvulsants and the risk of major congenital malformations.
    Charlton RA; Weil JG; Cunnington MC; Ray S; de Vries CS
    Drug Saf; 2011 Feb; 34(2):157-71. PubMed ID: 21247222
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Maternal valproate dosage and foetal malformations.
    Vajda FJ; Eadie MJ
    Acta Neurol Scand; 2005 Sep; 112(3):137-43. PubMed ID: 16097954
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pregnancy, delivery, and outcome for the child in maternal epilepsy.
    Veiby G; Daltveit AK; Engelsen BA; Gilhus NE
    Epilepsia; 2009 Sep; 50(9):2130-9. PubMed ID: 19490036
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antiepileptic drug use during pregnancy: perinatal outcomes.
    Kulaga S; Sheehy O; Zargarzadeh AH; Moussally K; Bérard A
    Seizure; 2011 Nov; 20(9):667-72. PubMed ID: 21763158
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Teratogenicity of the newer antiepileptic drugs--the Australian experience.
    Vajda FJ; Graham J; Roten A; Lander CM; O'Brien TJ; Eadie M
    J Clin Neurosci; 2012 Jan; 19(1):57-9. PubMed ID: 22104350
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dose-dependent teratogenicity of valproate in mono- and polytherapy: an observational study.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Perucca E; Sabers A; Thomas SV; Vajda F;
    Neurology; 2015 Sep; 85(10):866-72. PubMed ID: 26085607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is lamotrigine a significant human teratogen? Observations from the Australian Pregnancy Register.
    Vajda FJ; Graham JE; Hitchcock AA; O'Brien TJ; Lander CM; Eadie MJ
    Seizure; 2010 Nov; 19(9):558-61. PubMed ID: 20739196
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-dependent risk of malformations with antiepileptic drugs: an analysis of data from the EURAP epilepsy and pregnancy registry.
    Tomson T; Battino D; Bonizzoni E; Craig J; Lindhout D; Sabers A; Perucca E; Vajda F;
    Lancet Neurol; 2011 Jul; 10(7):609-17. PubMed ID: 21652013
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiepileptic drugs and foetal malformation: analysis of 20 years of data in a pregnancy register.
    Vajda FJE; Graham JE; Hitchcock AA; Lander CM; O'Brien TJ; Eadie MJ
    Seizure; 2019 Feb; 65():6-11. PubMed ID: 30593875
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Teratogenesis associated with antibipolar agents.
    Nguyen HT; Sharma V; McIntyre RS
    Adv Ther; 2009 Mar; 26(3):281-94. PubMed ID: 19330496
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Valproate and the risk for congenital malformations: Is formulation and dosage regime important?
    Mawhinney E; Campbell J; Craig J; Russell A; Smithson W; Parsons L; Robertson I; Irwin B; Morrison P; Liggan B; Delanty N; Hunt S; Morrow J
    Seizure; 2012 Apr; 21(3):215-8. PubMed ID: 22364656
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Australian pregnancy registry of women taking antiepileptic drugs.
    Vajda F; Lander C; O'brien T; Hitchcock A; Graham J; Solinas C; Eadie M; Cook M
    Epilepsia; 2004 Nov; 45(11):1466. PubMed ID: 15509252
    [No Abstract]   [Full Text] [Related]  

  • 20. Maternal use of antiepileptic drugs and the risk of major congenital malformations: a joint European prospective study of human teratogenesis associated with maternal epilepsy.
    Samrén EB; van Duijn CM; Koch S; Hiilesmaa VK; Klepel H; Bardy AH; Mannagetta GB; Deichl AW; Gaily E; Granström ML; Meinardi H; Grobbee DE; Hofman A; Janz D; Lindhout D
    Epilepsia; 1997 Sep; 38(9):981-90. PubMed ID: 9579936
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.